Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Mallinckrodt
Medtronic
Baxter
McKesson

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lapachone

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Lapachone?

Lapachone is an investigational drug.

There have been 6 clinical trials for Lapachone. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Metabolic Syndrome X, Pancreatic Neoplasms, and [disabled in preview]. The leading clinical trial sponsors are University of Texas Southwestern Medical Center, KT&G Life Sciences Corp, and KT&G Corporation.

Recent Clinical Trials for Lapachone
TitleSponsorPhase
ARQ761 + PARP Inhibitor in Refractory Solid TumorsUniversity of Texas Southwestern Medical CenterPhase 1
ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic CancerUniversity of Texas Southwestern Medical CenterPhase 1
Clinical Trial of ARQ 761 in Advanced Solid TumorsArQulePhase 1

See all Lapachone clinical trials

Clinical Trial Summary for Lapachone

Top disease conditions for Lapachone
Top clinical trial sponsors for Lapachone

See all Lapachone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Medtronic
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.